These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25036559)

  • 1. Late-onset dysferlinopathy presented as "liver enzyme" abnormalities: a technical note.
    Li F; Yin G; Xie Q; Shi G
    J Clin Rheumatol; 2014 Aug; 20(5):275-7. PubMed ID: 25036559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dysferlinopathy masquerading as a refractory polymyositis].
    Loureiro Amigo J; Gallardo E; Gallano P; Grau-Junyent JM
    Med Clin (Barc); 2015 Nov; 145(9):414-5. PubMed ID: 25662721
    [No Abstract]   [Full Text] [Related]  

  • 3. Heterogeneous characteristics of Korean patients with dysferlinopathy.
    Park HJ; Hong JM; Suh GI; Shin HY; Kim SM; Sunwoo IN; Suh BC; Choi YC
    J Korean Med Sci; 2012 Apr; 27(4):423-9. PubMed ID: 22468107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis by protein analysis of dysferlinopathy in two patients mistaken as polymyositis.
    Angelini C; Grisold W; Nigro V
    Acta Myol; 2011 Dec; 30(3):185-7. PubMed ID: 22616201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysferlinopathy misdiagnosed with juvenile polymyositis in the pre-symptomatic stage of hyperCKemia: a case report and literature review.
    Contreras-Cubas C; Barajas-Olmos F; Frayre-Martínez MI; Siordia-Reyes G; Guízar-Sánchez CC; García-Ortiz H; Orozco L; Baca V
    BMC Med Genomics; 2022 Jun; 15(1):139. PubMed ID: 35725460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late onset in dysferlinopathy widens the clinical spectrum.
    Klinge L; Dean AF; Kress W; Dixon P; Charlton R; Müller JS; Anderson LV; Straub V; Barresi R; Lochmüller H; Bushby K
    Neuromuscul Disord; 2008 Apr; 18(4):288-90. PubMed ID: 18396043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ["Therapy-resistant polymyositis" - is the diagnosis correct?].
    Ceccon G; Lehmann HC; Neuen-Jacob E; Meng G; Fink GR; Wunderlich G
    Z Rheumatol; 2017 Sep; 76(7):640-643. PubMed ID: 28523511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limb-girdle muscular dystrophy type 2B misdiagnosed as polymyositis at the early stage: Case report and literature review.
    Xu C; Chen J; Zhang Y; Li J
    Medicine (Baltimore); 2018 May; 97(21):e10539. PubMed ID: 29794729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late onset dysferlinopathy mimicking treatment resistant polymyositis.
    Griger Z; Nagy-Vincze M; Bodoki L; Gherardi RK; Dankó K; Hortobágyi T
    Joint Bone Spine; 2016 May; 83(3):355-6. PubMed ID: 26471412
    [No Abstract]   [Full Text] [Related]  

  • 10. The same answer using a simpler method: diagnosis in dysferlin muscle disease.
    Wicklund MP
    Muscle Nerve; 2014 Sep; 50(3):313-4. PubMed ID: 25042040
    [No Abstract]   [Full Text] [Related]  

  • 11. A case of dysferlinopathy presenting choreic movements.
    Takahashi T; Aoki M; Imai T; Yoshioka M; Konno H; Higano S; Onodera Y; Saito H; Kimura I; Itoyama Y
    Mov Disord; 2006 Sep; 21(9):1513-5. PubMed ID: 16817213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limb-Girdle Muscular Dystrophy 2B and Miyoshi Presentations of Dysferlinopathy.
    Patel NJ; Van Dyke KW; Espinoza LR
    Am J Med Sci; 2017 May; 353(5):484-491. PubMed ID: 28502335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysferlin deficiency treated like refractory polymyositis.
    Vinit J; Samson M; Gaultier JB; Laquerriere A; Ollagnon E; Petiot P; Marie I; Levesque H; Rousset H
    Clin Rheumatol; 2010 Jan; 29(1):103-6. PubMed ID: 19730931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic overview of blood-based dysferlin protein assay for dysferlinopathies.
    Ankala A; Nallamilli BR; Rufibach LE; Hwang E; Hegde MR
    Muscle Nerve; 2014 Sep; 50(3):333-9. PubMed ID: 24488599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward an objective measure of functional disability in dysferlinopathy.
    Woudt L; Di Capua GA; Krahn M; Castiglioni C; Hughes R; Campero M; Trangulao A; González-Hormazábal P; Godoy-Herrera R; Lévy N; Urtizberea JA; Jara L; Bevilacqua JA
    Muscle Nerve; 2016 Jan; 53(1):49-57. PubMed ID: 25900324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysferlinopathy: spectrum of pathological changes in skeletal muscle tissue.
    Gayathri N; Alefia R; Nalini A; Yasha TC; Anita M; Santosh V; Shankar SK
    Indian J Pathol Microbiol; 2011; 54(2):350-4. PubMed ID: 21623088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe respiratory and skeletal muscles involvement in a carrier of dysferlinopathy with chronic obstructive pulmonary disease.
    Fuschillo S; Torrente Y; Balzano G
    Respir Care; 2010 Aug; 55(8):1091-3. PubMed ID: 20667157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The limb-girdle muscular dystrophies.
    Wicklund MP; Kissel JT
    Neurol Clin; 2014 Aug; 32(3):729-49, ix. PubMed ID: 25037088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dysferlinopathy as an extrahepatic cause for the elevation of serum transaminases].
    Brüss M; Homann J; Molderings GJ
    Med Klin (Munich); 2004 Jun; 99(6):326-9. PubMed ID: 15221058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle inflammation, autoimmune Addison's disease and sarcoidosis in a patient with dysferlin deficiency.
    Selva-O'Callaghan A; Labrador-Horrillo M; Gallardo E; Herruzo A; Grau-Junyent JM; Vilardell-Tarres M
    Neuromuscul Disord; 2006 Mar; 16(3):208-9. PubMed ID: 16483775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.